Drug Shortage Report for DIAZEPAM INJECTION USP

Last updated on 2020-05-21 History
Report ID 115413
Drug Identification Number 02385392
Brand name DIAZEPAM INJECTION USP
Common or Proper name DIAZEPAM INJECTION USP
Company Name TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
Market Status DORMANT
Active Ingredient(s) DIAZEPAM
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2 mL
ATC code N05BA
ATC description ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-20
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-05-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 105 LINCOLN AVE
BUENA, NEW JERSEY
UNITED STATES 08310
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-05-21 English Compare
v4 2020-05-20 French Compare
v3 2020-05-20 English Compare
v2 2020-05-20 English Compare
v1 2020-05-20 English Compare

Showing 1 to 5 of 5